Fennec Pharmaceuticals (TSX:FRX) Market Cap : C$340.92 Mil (As of Apr. 28, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Fennec Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Fennec Pharmaceuticals's share price for the quarter that ended in Dec. 2023 was C$15.16. Fennec Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 27.03 Mil. Therefore, Fennec Pharmaceuticals's market cap for the quarter that ended in Dec. 2023 was C$409.73 Mil.

Fennec Pharmaceuticals's quarterly market cap declined from Jun. 2023 (C$328.98 Mil) to Sep. 2023 (C$267.28 Mil) but then increased from Sep. 2023 (C$267.28 Mil) to Dec. 2023 (C$409.73 Mil).

Fennec Pharmaceuticals's annual market cap increased from Dec. 2021 (C$145.68 Mil) to Dec. 2022 (C$345.07 Mil) and increased from Dec. 2022 (C$345.07 Mil) to Dec. 2023 (C$409.73 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Fennec Pharmaceuticals's Enterprise Value for Today is C$365.07 Mil.

Fennec Pharmaceuticals Market Cap Historical Data

The historical data trend for Fennec Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fennec Pharmaceuticals Market Cap Chart

Fennec Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

168.12

236.37

145.68

345.07

409.73

Fennec Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Market Cap	Get a 7-Day Free Trial															345.07	290.52	328.98	267.28	409.73

Competitive Comparison of Fennec Pharmaceuticals's Market Cap

For the Biotechnology subindustry, Fennec Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fennec Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fennec Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Fennec Pharmaceuticals's Market Cap falls into.

Fennec Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Fennec Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	C$15.16	*	27.027
	=	C$409.73

Fennec Pharmaceuticals's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	C$15.16	*	27.027
	=	C$409.73

Fennec Pharmaceuticals (TSX:FRX) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Fennec Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Fennec Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Fennec Pharmaceuticals (TSX:FRX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fennec Pharmaceuticals Inc (TSX:FRX) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

FENC:USA RV41:Germany

Address

68 TW Alexander Drive, PO Box 13628, Research Triangle Park, NC, USA, 27709

Website

https://www.fennecpharma.com

Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children. The company principally operates in the United States.